Metabolicke centrum MUDr. Katariny Raslovej, s.r.o.

Bratislava 83301

0 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Disease, Diabetes Mellitus, Type 2, Familial Chylomicronemia Syndrome, Type 2 Diabetes Mellitus

Studies at this site

• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes — Completed